Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Abdool Karim, Quarraisha, Abdool Karim, Salim S., Frohlich, Janet A., Grobler, Anneke C., Baxter, Cheryl, Mansoor, Leila E., Kharsany, Ayesha B. M., Sibeko, Sengeziwe, Mlisana, Koleka P., Omar, Zaheen, Gengiah, Tanuja N., Maarschalk, Silvia, Arulappan, Natasha, Mlotshwa, Mukelisiwe, Morris, Lynn, Taylor, Douglas, on behalf of the CAPRISA 004 Trial Group·2010·Science

DOI 10.1126/science.1193748

Cited by (1,005)

Items 601–700 of 1,005

Redesigning the AIDS response for long-term impact
Heidi Jane Larson, Stefano Bertozzi, Peter K. Piot · 2011 · Bulletin of the World Health Organization
Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1
Laura E. McCoy, Lucy Rutten, Dan Frampton, Ian Anderson, Luke A. Granger, Rachael J. M. Bashford-Rogers, Gillian Dekkers, Nika M. Strokappe, Michael S. Seaman, Willie Koh et al. · 2014 · PLoS Pathogens
Cervicovaginal Inflammation Facilitates Acquisition of Less Infectious HIV Variants
Philippe Selhorst, Lindi Masson, Sherazaan D. Ismail, Natasha Samsunder, Nigel Garrett, Leila Essop Mansoor, Quarraisha Abdool Karim, Salim S. Abdool Karim, Jo-Ann Shelley Passmore, Carolyn E. Williamson · 2016 · Clinical Infectious Diseases
Women-specific routes of administration for drugs: A critical overview
José das Neves, Fernando Notario-Pérez, Bruno Filipe Carmelino Cardoso Sarmento · 2021 · Advanced Drug Delivery Reviews
Mathematical Modeling of HIV Prevention Measures Including Pre-Exposure Prophylaxis on HIV Incidence in South Korea
Sun Bean Kim, Myoungho Yoon, Nam Su Ku, Min Hyung Kim, Je Eun Song, Jin Young Ahn, Su Jin Jeong, Changsoo Kim, Hee‐Dae Kwon, Jeehyun Lee et al. · 2014 · PLoS ONE
Tenofovir and adefovir down-regulate mitochondrial chaperone TRAP1 and succinate dehydrogenase subunit B to metabolically reprogram glucose metabolism and induce nephrotoxicity
Xinbin Zhao, Kun Sun, Zhou Lan, Wenxin Song, Lili Cheng, Wenna Chi, Jing Chen, Yi Huo, Lina Xu, Xiaohui Liu et al. · 2017 · Scientific Reports
Global Health: The Fogarty International Center, National Institutes of Health: Vision and Mission, Programs, and Accomplishments
Joel G. Breman, Kenneth Bridbord, Linda E. Kupfer, Roger I. Glass · 2011 · Infectious Disease Clinics of North America
Recent advances on anti-HIV vaginal delivery systems development
Sophia G. Antimisiaris, Spyridon Mourtas · 2015 · Advanced Drug Delivery Reviews
Evidence and AIDS activism: HIV scale-up and the contemporary politics of knowledge in global public health
Christopher James Colvin · 2014 · Global Public Health
Transmission Selects for HIV-1 Strains of Intermediate Virulence: A Modelling Approach
George Shirreff, Lorenzo Pellis, Oliver B Laeyendecker, Christophe Fraser · 2011 · PLoS Computational Biology
HIV Testing: Current Practice and Future Directions
Peter Cherutich, Rebecca E. Bunnell, Jonathan Mermin · 2013 · Current HIV/AIDS Reports
Evaluation of Rapidly Disintegrating Vaginal Tablets of Tenofovir, Emtricitabine and Their Combination for HIV-1 Prevention
Meredith R. Clark, M. Peet, Sarah Davis, Gustavo F. Doncel, David R. Friend · 2014 · Pharmaceutics
HIV Prevention Counseling Intervention Delivered During Routine Clinical Care Reduces HIV Risk Behavior in HIV-Infected South Africans Receiving Antiretroviral Therapy
Jeffrey D. Fisher, Deborah H. Cornman, Paul A. Shuper, Sarah Christie, Sandy Pillay, Susan E. MacDonald, Ntombenhle Judith Ngcobo, K. Rivet Amico, Umesh Lalloo, Gerald H Friedland et al. · 2014 · JAIDS Journal of Acquired Immune Deficiency Syndromes
The changing face of the HIV epidemic in sub‐ S aharan A frica
Portia Chipo Mutevedzi, Marie‐Louise Newell · 2014 · Tropical Medicine & International Health
HIV Prevention Interventions to Reduce Racial Disparities in the United States: A Systematic Review
Vagish S. Hemmige, Rachel B. McFadden, Scott C. Cook, Hui Nee Tang, John A. Schneider · 2012 · Journal of General Internal Medicine
HIV, Sexual Health, and Psychosocial Issues Among Older Adults Living with HIV in North America
David J. Brennan, Charles A. Emlet, Angela Eady · 2011 · Ageing International
Sex work and HIV in Cambodia: trajectories of risk and disease in two cohorts of high-risk young women in Phnom Penh, Cambodia
Kimberly Ann Page, Ellen S. Stein, Neth Sansothy, Jennifer L. Evans, Marie-Claude Couture, Keo Sichan, Melissa Cockroft, Julie Mooney‐Somers, Pisith Phlong, John Martin Kaldor et al. · 2013 · BMJ Open
Protection against Rectal Transmission of an Emtricitabine-Resistant Simian/Human Immunodeficiency Virus SHIV162p3M184VMutant by Intermittent Prophylaxis with Truvada
Mian-er Cong, Ae S. Youngpairoj, Qi Zheng, Wutyi S. Aung, James Michael Mitchell, Elizabeth D. Sweeney, Debra L. Hanson, R. Michael Hendry, Charles Dobard, Walid Heneine et al. · 2011 · Journal of Virology
Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model
Christopher J. Destache, Subhra Mandal, Zhe Yuan, Guobin Kang, Abhijit A. Date, Wuxun Lu, Annemarie Shibata, Rachel N. Pham, Patrick T. Bruck, Michael Rezich et al. · 2016 · Antimicrobial Agents and Chemotherapy
Epithelium-innate immune cell axis in mucosal responses to SIV
L. Shang, Lijie Duan, Katherine Perkey, Stephen W. Wietgrefe, Mary Zupancic, Anthony J. Smith, Peter J. Southern, R. Paul Johnson, Ashley T. Haase · 2016 · Mucosal Immunology
Sexual Behavior and Vaginal Practices During Pregnancy and Postpartum: Implications for HIV Prevention Strategies
John Kinuthia, Barbra A. Richardson, Alison L. Drake, Daniel N. Matemo, Jennifer A. Unger, Raymond Scott McClelland, Grace C. John-Stewart · 2016 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Optimized hydration dynamics in mucoadhesive xanthan-based trilayer vaginal films for the controlled release of tenofovir
Araceli Martín-Illana, Eva Chinarro, Raúl Cazorla-Luna, Fernando Notario-Pérez, María Dolores Veiga-Ochoa, Juan Rubio, Aitana Tamayo · 2021 · Carbohydrate Polymers
Virological efficacy and immunological recovery among Ethiopian HIV-1 infected adults and children
Andargachew Mulu, Uwe G. Liebert, Melanie Maier · 2014 · BMC Infectious Diseases
An Intravaginal Ring for the Sustained Delivery of Antibodies
Manjula Gunawardana, Marc M. Baum, Thomas J. Smith, John A. Moss · 2014 · Journal of Pharmaceutical Sciences
Vaginally Administered PEGylated LIF Antagonist Blocked Embryo Implantation and Eliminated Non-Target Effects on Bone in Mice
Ellen Melaleuca Menkhorst, Jian‐Guo Zhang, Natalie A. Sims, Phillip O. Morgan, Priscilla Soo, Ingrid J. Poulton, Donald Metcalf, Estella Alexandrou, Melissa M. Gresle, Lois A. Salamonsen et al. · 2011 · PLoS ONE
Female Genital Tract Secretions and Semen Impact the Development of Microbicides for the Prevention of HIV and Other Sexually Transmitted Infections
Betsy C. Herold, Pedro M. M. Mesquita, Rebecca Pellett Madan, Marla J. Keller · 2010 · American Journal of Reproductive Immunology
Dual Use of Long-Acting Reversible Contraceptives and Condoms Among Adolescents
Rebekah L. Williams, J. Dennis Fortenberry · 2013 · Journal of Adolescent Health
Beyond Virological Suppression: The Role of Adherence in the Late Haart Era
Adriana Ammassari, Maria Paola Trotta, Noga Shalev, Patrizia Marconi, Andrea Antinori · 2012 · Antiviral Therapy
Animal models for microbicide safety and efficacy testing
Ronald S. Veazey · 2013 · Current Opinion in HIV and AIDS
An empirical test of the Theory of Planned Behaviour applied to contraceptive use in rural Uganda
Susan M. Kiene, Sarah Hopwood, Haruna Lule, Rhoda K. Wanyenze · 2013 · Journal of Health Psychology
Sulfated Polysaccharides in Marine Sponges: Extraction Methods and Anti-HIV Activity
Ana I. S. Esteves, Marisa Nicolai, Madalena Humanes, João Gonçalves · 2011 · Marine Drugs
Homeostatic properties of Lactobacillus jensenii engineered as a live vaginal anti-HIV microbicide
Hidemi S. Yamamoto, Qiang Xu, Raina Nakova Fichorova · 2013 · BMC Microbiology
Preclinical Evaluation of the HIV-1 Fusion Inhibitor L'644 as a Potential Candidate Microbicide
Sarah Harman, Carolina Herrera, Naomi Armanasco, Jeremy P. Nuttall, Robin J. Shattock · 2012 · Antimicrobial Agents and Chemotherapy
A Modified Zinc Acetate Gel, a Potential Nonantiretroviral Microbicide, Is Safe and Effective against Simian-Human Immunodeficiency Virus and Herpes Simplex Virus 2 Infection In Vivo
Jessica Kenney, Aixa Rodríguez, Larisa Kizima, Samantha Seidor, Radhika Menon, Ninochka Jean‐Pierre, Pavel Pugach, Keith Levendosky, Nina R. Derby, Agegnehu Gettie et al. · 2013 · Antimicrobial Agents and Chemotherapy
Given Financial Constraints, It Would Be Unethical To Divert Antiretroviral Drugs From Treatment To Prevention
Ruth Macklin, Ethan A. Cowan · 2012 · Health Affairs
Pre-exposure prophylaxis for conception (PrEP-C) as a risk reduction strategy in HIV-positive men and HIV-negative women in the UK
Jennifer Whetham, Stephen R. Taylor, L. Charlwood, Tricia Keith, Richard J.S. Howell, C. McInnes, E. Payne, Jennifer Home, David White, Yvonne C. Gilleece · 2013 · AIDS Care
ART influences HIV persistence in the female reproductive tract and cervicovaginal secretions
Rikke Olesen, Michael D. Swanson, Martina Kovářová, Tomonori Nochi, Morgan Chateau, Jenna B. Honeycutt, Julie M. Long, Paul W. Denton, Michael G. Hudgens, Amy Richardson et al. · 2016 · Journal of Clinical Investigation
Development of disulfiram-loaded vaginal rings for the localised treatment of cervical cancer
Peter Boyd, Ian Major, Weiguang Wang, Christopher McConville · 2014 · European Journal of Pharmaceutics and Biopharmaceutics
Development of a vaginal delivery film containing EFdA, a novel anti-HIV nucleoside reverse transcriptase inhibitor
Wei Zhang, Michael A. Parniak, Stefan G. Sarafianos, Marilyn R. Cost, Lisa Cencia Rohan · 2013 · International Journal of Pharmaceutics
First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics
Barbara Friedland, Craig J. Hoesley, Marlena Gehret Plagianos, Elena K. Hoskin, Shimin Zhang, Natalia Teleshova, Mohcine Alami, Lea Novak, Kyle Kleinbeck, Lauren L. Katzen et al. · 2016 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Post-exposure prophylaxis for HIV infection
David Rey · 2011 · Expert Review of Anti-infective Therapy
Enhanced activity of carbosilane dendrimers against HIV when combined with reverse transcriptase inhibitor drugs: searching for more potent microbicides
María Ángeles Muñoz‐Fernández, F. Javier de la Mata, Marjorie Pion, Enrique Vacas‐Córdoba, Marta Galán, Rafael Gómez · 2014 · International Journal of Nanomedicine
Human viral diseases: what is next for antiviral drug discovery?
Erik De Clercq · 2012 · Current Opinion in Virology
Preclinical assessments of vaginal microbicide candidate safety and efficacy
José A. Fernández-Romero, Natalia Teleshova, Thomas M. Zydowsky, Melissa Robbiani · 2014 · Advanced Drug Delivery Reviews
Antiretroviral Therapy for Prevention Is a Combination Strategy
Margaret L. McNairy, Myron S. Cohen, Wafaa M. El-Sadr · 2013 · Current HIV/AIDS Reports
Controlling the HIV Epidemic with Antiretrovirals
Kenneth Hugh Mayer, Brian Gazzard, José M Zuniga, K. Rivet Amico, Jane Anderson, Yusef Azad, Gus Cairns, Nikos Dedes, Chris J. Duncombe, Sarah J. Fidler et al. · 2013 · Journal of the International Association of Providers of AIDS Care (JIAPAC)
Efficient Single Tobamoviral Vector-Based Bioproduction of Broadly Neutralizing Anti-HIV-1 Monoclonal Antibody VRC01 in Nicotiana benthamiana Plants and Utility of VRC01 in Combination Microbicides
Krystal Teasley Hamorsky, Tiffany W. Grooms-Williams, Adam S. Husk, Lauren J. Bennett, Kenneth E. Palmer, Nobuyuki Matoba · 2013 · Antimicrobial Agents and Chemotherapy
Microbial biofilms on the surface of intravaginal rings worn in non-human primates
Manjula Gunawardana, John A. Moss, Thomas J. Smith, Sean Kennedy, Etana G. Kopin, Cali Nguyen, Amanda M. D. Malone, Lorna K. Rabe, Christoph Schaudinn, Paul Christopher Webster et al. · 2011 · Journal of Medical Microbiology
High Medication Adherence During Periconception Periods Among HIV-1–Uninfected Women Participating in a Clinical Trial of Antiretroviral Pre-exposure Prophylaxis
Lynn T. Matthews, Renee A. Heffron, Nelly Mugo, Craig R. Cohen, Craig W. Hendrix, Connie Celum, David R. Bangsberg, Jared M. Baeten · 2014 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Tackling HIV and AIDS: contributions by non-human primate models
Koen K. A. Van Rompay · 2017 · Lab Animal
Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol
Malika Sharma, Allison Chris, Arlene Chan, David C. Knox, James Wilton, Owen McEwen, Sharmistha Mishra, Daniel Grace, Tim Rogers, Ahmed M. Bayoumi et al. · 2018 · BMC Health Services Research
HIV risk and pre-exposure prophylaxis interest among female bar workers in Dar es Salaam: cross-sectional survey
Guy Harling, Aisa Muya, Katrina F. Ortblad, Irene Mashasi, Peter Dambach, Nzovu K. Ulenga, Dale A. Barnhart, Eric Mboggo, Catherine E. Oldenburg, Till Bärnighausen et al. · 2019 · BMJ Open
Using discrete choice experiments to inform the design of complex interventions
The VMMC study team, Fern Terris‐Prestholt, Nyasule Majura Neke, Jonathan M. Grund, Marya Plotkin, Evodius Kuringe, Haika Osaki, Jason J. Ong, Joseph D. Tucker, Gerry Hillary Mshana et al. · 2019 · Trials
Human Resource Challenges to Integrating HIV Pre-Exposure Prophylaxis (PrEP) into the Public Health System in Kenya: A Qualitative Study.
Natasha Mack, Christina Wong, Kevin McKenna, Ansley Lemons, Jacob O. Odhiambo, Kawango E. Agot · 2015 · African Journal of Reproductive Health
Glycerol Monolaurate Microbicide Protection against Repeat High-Dose SIV Vaginal Challenge
Ashley T. Haase, Eva G. Rakasz, NANCY J. SCHULTZ‐DARKEN, Karla R. Nephew, Kimberly L. Weisgrau, Cavan Reilly, Qingsheng Li, Peter J. Southern, Meghan K. Rothenberger, Marnie L. Peterson et al. · 2015 · PLoS ONE
HIV Incidence Among Non-Pregnant Women Living in Selected Rural, Semi-Rural and Urban Areas in Kwazulu-Natal, South Africa
Gita Ramjee, Handan C. Wand, Claire Whitaker, Sheena McCormack, NANCY S. PADIAN, Cliff Kelly, Andrew Nunn · 2011 · AIDS and Behavior
Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD4+ immune cells
Emmanuel A. Ho, Yufei Andy Chen, Dash, Casey L. Sayre, Neal M. Davies, Gu, Sidi Yang · 2013 · International Journal of Nanomedicine
Parameterising User Uptake in Economic Evaluations: The role of discrete choice experiments
Fern Terris‐Prestholt, Matthew Quaife, Peter T. Vickerman · 2016 · Health Economics
Experience in international clinical research: the HIV Prevention Trials Network
Nirupama Sista, Quarraisha Abdool Karim, Kathy Hinson, Deborah J Donnell, Susan H. Eshleman, Sten H. Vermund · 2011 · Clinical Investigation
Translation of Biomedical Prevention Strategies for HIV
Sten H. Vermund, José A. Tique, Holly M. Cassell, Megan E. Pask, Philip J. Ciampa, Carolyn Marie Audet · 2013 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Combination HIV Prevention Interventions: The Potential of Integrated Behavioral and Biomedical Approaches
Jennifer L. Brown, Jessica McDermott Sales, Ralph Joseph DiClemente · 2014 · Current HIV/AIDS Reports
High HIV, HPV, and STI Prevalence Among Young Western Cape, South African Women
Anna R. Giuliano, Matthys Hendrik Botha, M. Zeier, Martha E. Abrahamsen, Richard Helmuth Glashoff, Louvina E. van der Laan, Mary R. Papenfuss, Susan Engelbrecht, Maarten F. Schim van der Loeff, Staci L. Sudenga et al. · 2014 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Tenofovir and tenofovir disoproxil fumarate pharmacokinetics from intravaginal rings
John A. Moss, Marc M. Baum, Amanda M. D. Malone, Sean Kennedy, Etana G. Kopin, Cali Nguyen, Joshua Gilman, Irina Butkyavichene, R. Willis, Kathleen L. Vincent et al. · 2011 · AIDS
Enrollment Characteristics and Risk Behaviors of Injection Drug Users Participating in the Bangkok Tenofovir Study, Thailand
Michael Martin, Suphak Vanichseni, Pravan Suntharasamai, Udomsak Sangkum, Rutt Chuachoowong, Philip A. Mock, Manoj Leethochawalit, Sithisat Chiamwongpaet, Somyot Kittimunkong, Frits van Griensven et al. · 2011 · PLoS ONE
Polyanionic Candidate Microbicides Accelerate the Formation of Semen-Derived Amyloid Fibrils to Enhance HIV-1 Infection
Suiyi Tan, Lu Lu, Lin Li, Jixiang Liu, Yelena Oksov, Hong Lü, Shibo Jiang, Shuwen Liu · 2013 · PLoS ONE
Lessons Learned from HIV Vaccine Clinical Efficacy Trials
Tracey Day, James G. Kublin · 2014 · Current HIV Research
Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial
Quarraisha Abdool Karim, Ayesha B. M. Kharsany, Janet Frohlich, Cheryl Baxter, Nonhlanhla Yende‐Zuma, Leila Essop Mansoor, Koleka Patience Mlisana, Silvia Maarschalk, Natasha Arulappan, Anneke C Grobler et al. · 2011 · Trials
Antiretroviral-Based HIV-1 Prevention: Antiretroviral Treatment and Pre-Exposure Prophylaxis
Connie Celum, Jared M. Baeten · 2012 · Antiviral Therapy
Differential Mechanisms of Tenofovir and Tenofovir Disoproxil Fumarate Cellular Transport and Implications for Topical Preexposure Prophylaxis
Ekaterina Taneva, Kerry Crooker, Sung Hyun Park, Jonathan T. Su, Adina K. Ott, Natalia Cheshenko, Igal G. Szleifer, Patrick F. Kiser, Bruce Frank, Pedro M. M. Mesquita et al. · 2015 · Antimicrobial Agents and Chemotherapy
Development and in Vitro Evaluation of a Microbicide Gel Formulation for a Novel Non-Nucleoside Reverse Transcriptase Inhibitor Belonging to the N-Dihydroalkyloxybenzyloxopyrimidines (N-DABOs) Family
Cristina Tintori, Annalaura Brai, Maria Chiara Dasso Lang, Davide Deodato, Greco Antonia Michela, Bruno Mattia Bizzarri, Cascone Lorena, Alexandru Casian, Claudio Zamperini, Elena Dreassi et al. · 2016 · Journal of Medicinal Chemistry
The Synthesis of Tenofovir and Its Analogues via Asymmetric Transfer Hydrogenation
Qian Zhang, Baiwei Ma, Qianqian Wang, Xingxing Wang, Xia Hu, Ming‐Sheng Xie, Gui‐Rong Qu, Hai‐Ming Guo · 2014 · Organic Letters
The association between substance use and sub-optimal HIV treatment engagement among HIV-infected female sex workers in Lilongwe, Malawi
Kathryn Elizabeth Lancaster, Thandie Lungu, Pearson Mmodzi, Mina C. Hosseinipour, Katy Chadwick, Kimberly A. Powers, Brian Wells Pence, Vivian Fei-ling Go, Irving Hoffman, William C. Miller · 2016 · AIDS Care
Investigating Organ Toxicity Profile of Tenofovir and Tenofovir Nanoparticle on the Liver and Kidney: Experimental Animal Study
Aniekan Imo Peter, Edwin Cs Naidu, Edidiong Nnamso Akang, Oluwatosin Olalekan Ogedengbe, Ugochukwu Offor, Sanjeev Rambharose, Rahul S. Kalhapure, Anil Amichund Chuturgoon, Thirumala Govender, Onyemaechi Okpara Azu · 2018 · Toxicological Research
Acceptability and Predictors of Uptake of Anti-retroviral Pre-exposure Prophylaxis (PrEP) Among Fishing Communities in Uganda: A Cross-Sectional Discrete Choice Experiment Survey
Monica O. Kuteesa, Matthew Quaife, Samuel Biraro, Kenneth Roger Katumba, Janet Seeley, Anatoli Kamali, Damalie Nakanjako · 2019 · AIDS and Behavior
Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection
Christopher McConville, Peter Boyd, Ian Major · 2014 · Clinical Medicine Insights Women s Health
Strengthening biostatistics resources in sub‐Saharan Africa: Research collaborations through U.S. partnerships
Misrak Gezmu, Victor G. DeGruttola, Dennis O. Dixon, Max Essex, Elizabeth Halloran, Joseph W. Hogan, Anneke C Grobler, Soyeon Kim, Jeanne M. McDermott, Rosemary G. McKaig et al. · 2011 · Statistics in Medicine
“Male Involvement” in Women and Children's HIV Prevention: Challenges in Definition and Interpretation
Elizabeth Montgomery, Ariane van der Straten, Kristine Torjesen · 2011 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Development of Methods for Cross-Sectional HIV Incidence Estimation in a Large, Community Randomized Trial
Oliver B Laeyendecker, Michal Kulich, Deborah J Donnell, Arnošt Komárek, Marek Omelka, Caroline E. Mullis, Greg Szekeres, Estelle Piwowar‐Manning, Agnès Fiamma, Ronald Henry Gray et al. · 2013 · PLoS ONE
Synergy against drug-resistant HIV-1 with the microbicide antiretrovirals, dapivirine and tenofovir, in combination
Susan M. Schader, Susan P. Colby-Germinario, Jordana R. Schachter, Hongtao Xu, Mark A. Wainberg · 2011 · AIDS
HIV pre‐exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research
Daniel J. Escudero, Mark N. Lurie, Thomas H Kerr, Chanelle J. Howe, Brandon D. L. Marshall · 2014 · Journal of the International AIDS Society
Methodological Lessons from Clinical Trials and the Future of Microbicide Research
Ariane van der Straten, Elizabeth Montgomery, Miriam Hartmann, Alexandra M. Minnis · 2012 · Current HIV/AIDS Reports
HIV Prevention Among Women in Low- and Middle-Income Countries: Intervening Upon Contexts of Heightened HIV Risk
Steffanie A. Strathdee, Wendee M. Wechsberg, Deanna L. Kerrigan, Thomas L. Patterson · 2013 · Annual Review of Public Health
Modeling and Cost-Effectiveness in HIV Prevention
Margo M. Wheatley, Rochelle P. Walensky · 2016 · Current HIV/AIDS Reports
Nondaily preexposure prophylaxis for HIV prevention
Peter L. Anderson, Jose Gerardo Garcia-Lerma, Walid Heneine · 2015 · Current Opinion in HIV and AIDS
Evaluation of PEPFAR
Youth Board on Children, Families · 2013
Pharmacokinetics and Preliminary Safety of Pod-Intravaginal Rings Delivering the Monoclonal Antibody VRC01-N for HIV Prophylaxis in a Macaque Model
Chunxia Zhao, Manjula Gunawardana, Francois J. Villinger, Marc M. Baum, Mariana Remedios-Chan, Thomas R. Moench, Larry Zeitlin, Kevin J. Whaley, Ognian Bohorov, Thomas J. Smith et al. · 2017 · Antimicrobial Agents and Chemotherapy
Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial
Kathleen L. Vincent, John A. Moss, Mark A. Marzinke, Craig W. Hendrix, Peter A. Anton, Richard B. Pyles, Kate Morrow Guthrie, Lauren N. Dawson, Trevelyn J. Olive, Irina Butkyavichene et al. · 2018 · PLoS Medicine
Pharmaceutical Vehicles for Vaginal and Rectal Administration of Anti-HIV Microbicide Nanosystems
Letícia Mesquita, Joana Galante, Rute Nunes, Bruno Filipe Carmelino Cardoso Sarmento, José das Neves · 2019 · Pharmaceutics
Development and characterisation of a self-microemulsifying drug delivery systems (SMEDDSs) for the vaginal administration of the antiretroviral UC-781
Christopher McConville, David R. Friend · 2012 · European Journal of Pharmaceutics and Biopharmaceutics
Health Care Providers: A Missing Link in Understanding Acceptability of The Female Condom
Joanne Ellen Mantell, Brooke S. West, Kimberly L. Sue, Susie Hoffman, Theresa M. Exner, Elizabeth A. Kelvin, ZENA A. STEIN · 2011 · AIDS Education and Prevention
Effects of HIV Antiretroviral Therapy on Sexual and Injecting Risk-Taking Behavior: A Systematic Review and Meta-analysis
Joseph Doyle, Louisa J Degenhardt, Alisa E. Pedrana, Emma Sue McBryde, Rebecca Guy, Mark A Stoove, Emma R. Weaver, Andrew Edwin Grulich, Ying-Ru Jacqueline Lo, Margaret Elena Hellard · 2014 · Clinical Infectious Diseases
In vitro profiling of the vaginal permeation potential of anti-HIV microbicides and the influence of formulation excipients
Carolien Grammen, Patrick Augustijns, Joachim Brouwers · 2012 · Antiviral Research
An Inducible Cell-Cell Fusion System with Integrated Ability to Measure the Efficiency and Specificity of HIV-1 Entry Inhibitors
Alon Herschhorn, Andrés Finzi, David M. Jones, Joel R. Courter, Akihiro Sugawara, Amos B. Smith, Joseph Sodroski · 2011 · PLoS ONE
Design and in vitro evaluation of tenofovir-loaded vaginal gels for the prevention of HIV infections
Selin Seda Timur, Adem Şahin, Eren Aytekin, Naile Öztürk, Heybet Kerem Polat, Nurten Tezel, Reyhan Neslihan Gürsoy, Sema Çalış · 2017 · Pharmaceutical Development and Technology
Ethical Considerations in Determining Standard of Prevention Packages for HIV Prevention Trials: Examining P r EP
Bridget Gabrielle Haire, Morẹ́nikẹ́ Oluwátóyìn Foláyan, Catherine A Hankins, Jeremy Sugarman, Sheena McCormack, Gita Ramjee H, Mitchell Warren · 2013 · Developing World Bioethics
HIV pre-exposure prophylaxis: Mucosal tissue drug distribution of RT inhibitor Tenofovir and entry inhibitor Maraviroc in a humanized mouse model
Milena Veselinović, Kuo-Hsiung Yang, Jonathan LeCureux, Craig Sykes, Leila Remling‐Mulder, Angela D. M. Kashuba, Ramesh Akkina · 2014 · Virology
Protection of HIV Neutralizing Aptamers against Rectal and Vaginal Nucleases
Michael D. Moore, Jonathan Cookson, Veronica K. Coventry, Brian S. Sproat, Lorna K. Rabe, Ross Cranston, Ian McGowan, William James · 2010 · Journal of Biological Chemistry
Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs
Jill M. Steinbach-Rankins · 2014 · Cellular and Molecular Life Sciences
Stigma impedes AIDS prevention
Salim S. Abdool Karim · 2011 · Nature
Future of Phylogeny in HIV Prevention
BLUMA G. BRENNER, Mark A. Wainberg · 2013 · JAIDS Journal of Acquired Immune Deficiency Syndromes